Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Gaya Wellness vs NexLife

Gaya Wellness
Graded #248

Lower grade

vs+4.800000000000004
NexLife
Graded #139

Higher grade

The verdict

NexLife takes it — 68.7/100 to 63.9/100.

NexLife grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NexLife is a LegitScript-certified telehealth platform offering compounded semaglutide (from $145/mo) and compounded tirzepatide (from $186/mo).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNexLife +39
32
71
Dose & formulationEven
64
64
Clinical oversightEven
89
89
Labs & monitoringGaya Wellness +44
97
53
FulfillmentNexLife +5
62
67
Contract termsNexLife +14
41
55
Gaya Wellness · left barNexLife · right bar

The numbers

MetricGaya WellnessNexLife
WeighScore63.9/10068.7/100
GradeCC
Scorecard rank#248#139
Semaglutide$349/mo (compounded)$165/mo (compounded)
Tirzepatide$349/mo (compounded)$215/mo (compounded)
Coverage5 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Gaya Wellness

Graded #248 · C

Strengths

  • OB/GYN-led care designed for women 40+ and menopause overlap
  • Includes a 50+ biomarker lab panel and weekly physician check-ins
  • HSA/FSA eligible with a GLP-1 plus bioidentical HRT bundle option
  • Transparent tiered pricing published online

Where it loses points

  • Weight loss is one vertical alongside menopause and hormone care
  • Medication-included tiers ($349+/mo) are pricier than many compounders
  • Available in only five states (FL, NC, VA, IN, TN)
NexLife

Graded #139 · C

Strengths

  • LegitScript certified platform
  • Works exclusively with LegitScript-certified, NABP-accredited pharmacies — strongest pharmacy trust signal in the dataset
  • Both semaglutide and tirzepatide at competitive pricing
  • Semaglutide from $145/mo on the 12-month plan ($165/mo month-to-month) - among the lowest in the dataset

Where it loses points

  • State availability not publicly disclosed
  • Compounded only — no brand-name options
  • Also covers hormone optimization and longevity
  • Lowest advertised rates ($145 sema / $186 tirz) require a 12-month plan commitment

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard